1. Altered response to thyroid hormones by prostate and breast cancer cells

   • M. B. Martinez
   • M. Ruan
   • L. A. Fitzpatrick

   ORIGINAL ARTICLE Pages: 93 - 102

2. Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

   • John D. Roberts
   • Elizabeth A. Poplin
   • Richard Moran

   ORIGINAL ARTICLE Pages: 103 - 110

3. Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen

   • Jeremy P. Braybrooke
   • Sue Houlbrook
   • Denis C. Talbot

   ORIGINAL ARTICLE Pages: 111 - 119

4. Different microtubule network alterations induced by pachymatismin, a new marine glycoprotein, on two prostatic cell lines

   • Suleeporn Sangrajrang
   • Mohamed Zidane
   • Arlette Fellous

   ORIGINAL ARTICLE Pages: 120 - 126

5. Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer

   • Daniela Gallo
   • Cristiano Ferlini
   • Giovanni Scambia

   ORIGINAL ARTICLE Pages: 127 - 132

6. Estrogen agonistic/antagonistic effects of miproxifene phosphate (TAT-59)

   • Jiro Shibata
   • Toshiyuki Toko
   • Yuji Yamada

   ORIGINAL ARTICLE Pages: 133 - 141

7. Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy

   • N. L. Lehman
   • P. V. Danenberg

   ORIGINAL ARTICLE Pages: 142 - 148

8. Actinomycin D and staurosporine, potent apoptosis inducers in vitro, are potentially effective chemotherapeutic agents against glioblastoma multiforme

   • Yoshitaka Narita
   • Akio Asai
   • Takaaki Kirino

   ORIGINAL ARTICLE Pages: 149 - 156

9. Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function

   • Claire Massari
   • Silvano Brienza
   • Gérard Bastian

   ORIGINAL ARTICLE Pages: 157 - 164

10. Impact of the simultaneous administration of the (+)- and (−)-forms of formyl-tetrahydrofolic acid on plasma and intracellular pharmacokinetics of (−)-tetrahydrofolic acid

    • Eberhard Schleyer
    • Karl Lenhard Rudolph
    • Wolfgang Kern

    ORIGINAL ARTICLE Pages: 165 - 171

11. In vitro antioxidant properties of amifostine (WR-2721, Ethyol)

    • Fulvio Marzatico
    • Camillo Porta
    • Laura Castagna

    ORIGINAL ARTICLE Pages: 172 - 176

12. Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study

    • Ofer Merimsky
    • Isaac Meller
    • for the Israeli Soft Tissue and Bone Sarcoma Treatment Groups

    CLINICAL TRIAL REPORT Pages: 177 - 181